Strand Therapeutics

cancer target detection radiopharma radio

Biotech

Big Pharmas back Strand's $153M series B to advance mRNA drugs

An impressive array of Big Pharma backers lined up to ensure Strand has the funds needed to advance its mRNA-based solid tumor drugs.

James Waldron Aug 7, 2025 9:20am

Fierce Biotech's 2022 Fierce 15

Sep 12, 2022 3:00am

mRNA vaccine

The mRNA era after COVID-19: What's next in the pipeline

Sep 1, 2021 11:28am

Strand Therapeutics Chief Operating Officer Samta Kundu CEO and co-founder Jake Becraft and President Head of RD and co-fo

Strand snags $52M to develop next-gen mRNA meds for cancer

Jun 23, 2021 8:00am